Sex as a biological variable in atherosclerosis

JJ Man, JA Beckman, IZ Jaffe - Circulation research, 2020 - Am Heart Assoc
Atherosclerosis is a chronic inflammatory vascular disease and the predominant cause of
heart attack and ischemic stroke. Despite the well-known sexual dimorphism in the …

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

A Iorga, CM Cunningham, S Moazeni… - Biology of sex …, 2017 - Springer
Epidemiologic studies have previously suggested that premenopausal females have
reduced incidence of cardiovascular disease (CVD) when compared to age-matched males …

Sex differences in mechanisms of arterial stiffness

JJ DuPont, RM Kenney, AR Patel… - British journal of …, 2019 - Wiley Online Library
Arterial stiffness progressively increases with aging and is an independent predictor of
cardiovascular disease (CVD) risk. Evidence supports that there are sex differences in the …

Why primate models matter

KA Phillips, KL Bales, JP Capitanio… - American journal of …, 2014 - Wiley Online Library
Research involving nonhuman primates (NHPs) has played a vital role in many of the
medical and scientific advances of the past century. NHPs are used because of their …

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

JE Rossouw, GL Anderson, RL Prentice, AZ LaCroix… - Jama, 2002 - escholarship.org
ContextDespite decades of accumulated observational evidence, the balance of risks and
benefits for hormone use in healthy postmenopausal women remains uncertain. ObjectiveTo …

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women

S Hulley, D Grady, T Bush, C Furberg, D Herrington… - Jama, 1998 - jamanetwork.com
Context.—Observational studies have found lower rates of coronary heart disease (CHD) in
postmenopausal women who take estrogen than in women who do not, but this potential …

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial

Writing Group for the Women's Health Initiative … - Jama, 2002 - jamanetwork.com
ContextDespite decades of accumulated observational evidence, the balance of risks and
benefits for hormone use in healthy postmenopausal women remains uncertain. ObjectiveTo …

Estrogen signaling and cardiovascular disease

E Murphy - Circulation research, 2011 - Am Heart Assoc
Estrogen has pleiotropic effects on the cardiovascular system. The mechanisms by which
estrogen confers these pleiotropic effects are undergoing active investigation. Until a …

Hormone therapy to prevent disease and prolong life in postmenopausal women

D Grady, SM Rubin, DB Petitti, CS Fox… - Annals of internal …, 1992 - acpjournals.org
▪ Purpose: To critically review the risks and benefits of hormone therapy for asymptomatic
postmenopausal women who are considering long-term hormone therapy to prevent …

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom …

LJ Shaw, CN Bairey Merz, CJ Pepine, SE Reis… - Journal of the American …, 2006 - jacc.org
Despite a dramatic decline in mortality over the past three decades, coronary heart disease
is the leading cause of death and disability in the US Importantly, recent advances in the …